Nils Hartmannn

Senior Advisor bei ctcHealth, einem Beratungs-Unternehmen, das Vertriebsmitarbeitern das nötige Wissen und die Fähigkeiten vermittelt, um KI und andere neue Technologien in ihrer täglichen Arbeit zu nutzen.

Interim-Management Lösungen und Beratungsprojekte für Pharmaunternehmen.

Head of Lilly's business operations in Poland with revenue of $128M and 140 employees. Accelerated affiliate revenue growth from historically 6-7% to 45% through successful expansion of product reimbursement and new product launches.

Head of global product strategy; responsible for the definition and execution of the global marketing strategy for Trulicity (type II diabetes; $7.4B sales in 2022). Successful Trulicity launch in China, including obtaining reimbursement. Lead for the strategy definition, launch readiness, and drug approval (FDA, EMA & PMDA) of BAQSIMI (inhalable nasal Glucagon).

Ensured correct implementation of global brand strategies in all international markets (except US/Canada) and consulted affiliates on priorities and correct implementation. Defined competitive launch strategy for Lilly insulin biosimilars.

Head of Lilly’s diabetes commercial operations in Germany, Austria, and Switzerland. First market outside the US to launch Trulicity, Jardiance, Basaglar, Humalog 200 with best-in-class launch uptakes. Extensive collaboration with Boehringer Ingelheim and Berlin Chemie.

Led 3 sales teams with 11 district sales managers and 87 sales representatives. Significant performance improvement for the two hospital sales teams (cardiology and pulmonary arterial hypertension) while exceeding revenue targets with the retail sales team (osteoporosis & erectile dysfunction).

Head of brand management for Byetta (type II diabetes). Successfully executed competitive strategy against a new market entrant.

Led 10 sales representatives. Improved district ranking with Zyprexa (schizophrenia & bipolar disorder) and Cymbalta (depressive and anxiety disorder) in 2007 and with Forsteo (osteoporosis) and Cymbalta in 2008/09.

Defined, implemented, and tracked affiliate priorities for executive team. Ran market research to identify weaknesses in the offered Continuous Medical Education (CME) and successfully launched new educational concepts. Repositioned and supervised a service force of 10 for nutritional consulting.

Launched the Dove hair care portfolio, strengthened Rexona's position in the deodorant category, and repositioned the male grooming brand Axe.

Projekt Managment, Führung, Marketing

Business Administration/Economics; Vertiefung Finanz- und Rechnungswesen, Marketing